Categories AlphaGraphs, Health Care

Krsnaa Diagnostics Q1 FY26 Earnings Results

Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns. Presenting below are its Q1 FY26 earnings results.

 

Q1 FY26 Earnings Results

  • Revenue from Operations: ₹176 crores, up 8% YoY (Q1 FY25: ₹170.2 crores).

  • EBITDA: ₹52.4 crores, up 19% YoY, with EBITDA margin improving to 27% (Q1 FY25: 26%).

  • Profit After Tax (PAT): ₹20.5 crores, up 11% YoY (Q1 FY25: ₹17.9 crores), PAT margin of 11%.

  • Earnings Per Share (EPS): ₹6.03, up 7% YoY.

  • Retail Touchpoints: Increased significantly from 362 to 2,414 in one year, with retail now contributing ~6% of total revenue.

  • Patient Served & Tests Conducted: 5 million patients served, 16 million tests performed in Q1.

  • Major Contract Win: Secured a large 5-year PPP pathology contract in Rajasthan involving 42 mother labs, 135 satellite labs, and 1,300+ collection centers; expected annual revenue of ₹300–350 crores on maturity, with ₹200–250 crores CapEx planned and phased implementation over 6–9 months.

  • Expansion: Added 3 labs, 2 CT scanners, and 3 MRI machines during the quarter.

 

Management Commentary & Strategic Highlights

  • MD Yash Mutha expressed optimism about the transformative Rajasthan PPP contract, which will significantly expand Krsnaa’s footprint and revenue base from FY27.

  • The company continues to focus on scaling retail diagnostics, improving operational efficiencies, and digital initiatives to sustain growth and margins.

  • Working capital has improved with overdue receivables from states like Himachal Pradesh and Karnataka beginning to clear, aiding cash flow stability.

  • Retail business projected to reach EBITDA breakeven by FY26 end, with revenue contribution expected to increase to 5–8% by FY26 and 18–20% within two years.

 

Krsnaa Diagnostics Q1 FY26 Earnings Results

 

Q4 FY25 Earnings Results

  • Revenue from Operations: ₹175 crores.

  • EBITDA: ₹44 crores; margin ~28%.

  • PAT: ₹21 crores.

  • EPS: ₹6.53.

 

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet India news channel.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top